The game between Esai, Ranbaxy, Teva and FDA for Aricept

I have came across a nice compiled study of the Aricept case. Recently Ranbaxy got the approval and entitled 180 days exclusivity and Teva's generic launch was delayed until the expiry of 180 days exclusivity of Ranbaxy.
The whole story is very well explained here